Prion-specific peptoid reagents

Details for Australian Patent Application No. 2006287299 (hide)

Owner Novartis AG

Inventors Connolly, Michael D.; Timoteo, Gulliver; Gao, Man; Peretz, David; Shimizu, Robert M.; Zuckermann, Ronald

Agent FB Rice

Pub. Number AU-B-2006287299

PCT Pub. Number WO2007/030804

Priority 60/726,686 14.10.05 US; 60/758,934 13.01.06 US; 60/715,761 09.09.05 US

Filing date 8 September 2006

Wipo publication date 15 March 2007

Acceptance publication date 23 August 2012

International Classifications

C07K 5/00 Peptides having up to four amino acids in a fully defined sequence

A61K 31/16 - Amides, e.g. hydroxamic acids

A61K 38/08 Medicinal preparations containing peptides - Peptides having 5 to 11 amino acids

A61K 38/10 Medicinal preparations containing peptides - Peptides having 12 to 20 amino acids

C07K 7/00 Peptides having 5 to 20 amino acids in a fully defined sequence

Event Publications

20 March 2008 PCT application entered the National Phase

  PCT publication WO2007/030804 Priority application(s): WO2007/030804

23 August 2012 Application Accepted

  Published as AU-B-2006287299

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006287305-Multiparameter whole blood monitor and method

2006287296-System and method for shared wins